MCV

What is MCV?

MCV (Mean Corpuscular Volume) is the average volume of a single red blood cell, measured in femtolitres (fL) by a haematology analyser. The reference range for adults is typically 80–100 fL. MCV is a direct measurement — not a calculation — and is therefore one of the most reliable indices in the complete blood count. It forms the basis of morphological anaemia classification: microcytic anaemia (MCV < 80 fL), normocytic anaemia (MCV 80–100 fL), and macrocytic anaemia (MCV > 100 fL). Microcytosis (MCV < 80 fL) is most often caused by iron deficiency — by far the most common form of anaemia worldwide. Other causes include thalassaemia trait (alpha or beta), anaemia of chronic disease (with prolonged inflammation or infection), and — rarely — lead poisoning or sideroblastic anaemia. Macrocytosis (MCV > 100 fL) is most often caused by vitamin B12 or folate deficiency, chronic excess alcohol use (even without anaemia), liver disease, hypothyroidism, and certain medications (methotrexate, hydroxyurea, some antiretrovirals). Normocytic anaemia (normal MCV) is seen in anaemia of chronic disease, kidney failure, acute blood loss, and haemolytic anaemia. MCV changes relatively slowly: with iron deficiency it may take weeks to months before MCV falls appreciably; with B12 supplementation it normalises over weeks to a few months. MCV is therefore a trend marker that indicates direction but responds slowly to acute changes.

Why is MCV relevant?

MCV is clinically valuable as the primary directional marker when evaluating anaemia or fatigue: morphological classification immediately guides which follow-up tests are worthwhile. A microcytic picture calls for iron status (ferritin, transferrin saturation, serum iron); a macrocytic picture for B12, folate, and thyroid function. Without that classification step, follow-up testing would need to be ordered blindly — making MCV a cost-effective first filter. An important caveat is the false normality with mixed deficiencies. If someone simultaneously has iron deficiency (which lowers MCV) and B12 deficiency (which raises MCV), both effects can cancel out and yield a normal MCV. RDW is then the key marker: with a mixed deficiency there is wide variation in cell size (anisocytosis), visible as an elevated RDW even though MCV appears normal. Normal MCV + elevated RDW + anaemia is therefore a pattern that warrants further evaluation. For people having preventive blood tests without reporting anaemia symptoms, an abnormal MCV is still clinically informative: early iron deficiency (low ferritin, MCV still in the low-normal zone) or subclinical B12 deficiency (MCV just above normal, with fatigue and tingling) can be detected before haemoglobin falls.

MCV high or low — what it means

MCV is rarely sufficient on its own — it is almost always read together with haemoglobin, haematocrit, MCH, MCHC, and RDW. With microcytosis, ferritin is the first follow-up test; if ferritin is normal with low MCV, the differential includes alpha or beta thalassaemia trait, anaemia of chronic disease (with CRP/ESR), and sideroblastic anaemia. With macrocytosis, B12 and folate are the first follow-up tests, followed by thyroid function and liver enzymes if the picture is unclear. RDW is the essential companion to MCV: the combination of MCV category and RDW status (normal or elevated) produces a 2×2 grid that refines the most likely diagnosis. Elevated RDW with low MCV fits iron deficiency; normal RDW with low MCV more often fits thalassaemia trait; elevated RDW with high MCV fits B12/folate deficiency; normal RDW with high MCV points more toward liver disease, alcohol, or medication-related macrocytosis. Trends across multiple measurements are more informative than a single reading: a falling MCV in someone who has stopped iron supplementation, or a rising MCV in someone on methotrexate, tells a story that a one-off measurement cannot.

Educational information only — not medical advice. Consult a healthcare professional for clinical decisions.